/bulletin
Do you have an interest in mRNA technologies, in particular mRNA vaccines? The European Patent Office (EPO) has published an insight report
The Enlarged Board of Appeal’s recent decision in consolidated cases G1/22 and G2/22 has greatly simplified the consideration of priority entitlement at
In Opposition and Appeal proceedings at the EPO, the questions of when and how to turn to the description to interpret the
With the recent expansion in artificial intelligence (AI) and machine learning technologies, and an associated rise in the number of AI related
A recent decision from the EPO’s Technical Boards of Appeal (T2803/18) highlights a pitfall for applicants wishing to patent systems and methods
As artificial intelligence (AI) continues to advance and transform various industries, the protection of AI-related inventions through patents becomes increasingly important. Artificial
China is proposing to overhaul its trade mark law, largely in an effort to combat the scourge of bad faith filings. On
The EPO’s plans to abolish the 10-day notification rule will come into force on 1 November 2023. With just a month to
The UK Intellectual Property Office (IPO) has recently updated its guidance relating to Address for Service (AFS) in the UK. The guidance
In June 2023, the US Senate proposed changes to US patent law to address patent subject matter eligibility, inter partes reviews and